FDA Drug Recalls

Recalls / Class II

Class IID-312-2013

Product

Daytrana (methylphenidate) transdermal system patch, Delivers 10 mg over 9 hours (1.1 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL 33186; NDC 68968-5552-3.

Brand name
Daytrana
Generic name
Methylphenidate
Active ingredient
Methylphenidate
Route
Transdermal
NDCs
68968-5552, 68968-5553, 68968-5554, 68968-5555
FDA application
NDA021514
Affected lot / code info
Lot #59824, Exp 04/13

Why it was recalled

Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.

Recalling firm

Firm
Noven Pharmaceuticals, Inc.
Manufacturer
Noven Therapeutics, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
11960 Sw 144th St, Miami, Florida 33186-6109

Distribution

Quantity
335,910 patches
Distribution pattern
Nationwide and Puerto Rico.

Timeline

Recall initiated
2013-01-31
FDA classified
2013-05-02
Posted by FDA
2013-05-08
Terminated
2016-12-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-312-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.